A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA
NCT02193945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134
Last updated 2015-07-09
Summary
The purpose of this study is to retrospectively review and further characterize anatomic and symptomatic changes over six months immediately following treatment of symptomatic vitreomacular adhesion (VMA) with JETREA® (ocriplasmin), including incidence, time to onset and resolution of anatomy and symptoms.
Conditions
- Symptomatic Vitreomacular Adhesion (VMA)
Sponsors & Collaborators
-
ThromboGenics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- United States
Study Locations
More Related Trials
-
Minocycline to Treat Branch Retinal Vein Occlusion
NCT01468831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201
NCT02956330 ·Status: COMPLETED
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion
NCT00970957 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
NCT01295112 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
NCT00943072 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
NCT05112861 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
NCT01581411 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
NCT01614509 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
NCT00348439 ·Status: TERMINATED ·Phase: PHASE2
-
Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
NCT02645747 ·Status: COMPLETED
-
Combined Triple Procedure in Retinal Vein Occlusion (RVO)
NCT00805064 ·Status: COMPLETED ·Phase: PHASE3
-
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment
NCT02287298 ·Status: COMPLETED
-
Central Vein Occlusion Study (CVOS)
NCT00000131 ·Status: COMPLETED ·Phase: PHASE3
-
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
NCT01053858 ·Status: COMPLETED ·Phase: NA
-
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
NCT01231633 ·Status: COMPLETED ·Phase: NA
-
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
NCT01946399 ·Status: TERMINATED ·Phase: NA
-
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
NCT00417833 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
NCT02800642 ·Status: COMPLETED ·Phase: PHASE4
-
Retina is a Marker for Cerebrovascular Heath
NCT04753970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
NCT03897192 ·Status: COMPLETED
-
Visual Outcome After Vitrectomy With Subretinal tPA Injection
NCT05196139 ·Status: COMPLETED
-
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
NCT02390531 ·Status: COMPLETED ·Phase: PHASE1